Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-16, Stock:JNJ, The news for the past five days is as follows:
2021-12-09: NEWS1: World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster.NEWS2: ‘The Days You Were Considered Fully Vaccinated With Two Shots Are Going to Be a Thing of the Past’.NEWS3: Astrazeneca president talks COVID-19 antibody treatment, vaccines, and Omicron.NEWS4: Omicron variant: Recent study on transmissibility is not ‘remotely conclusive,’ virologist says.NEWS5: J&J Has 'Tremendous, Deep Bench' of Leaders, CEO Says.NEWS6: Pfizer (PFE) COVID-19 Booster Gives Protection Against Omicron.NEWS7: J&J CEO Says Collective Effort Needed to Fight Omicron.NEWS8: Senate passes GOP bill to overturn President Biden’s vaccine mandate.NEWS9: Vaccines are the 'working seatbelts' for dealing with the Omicron coronavirus variant: Doctor.NEWS10: The Omicron variant is 4 times more transmissible than Delta: Study.NEWS11: 10 Dividend Stocks With Over 8% Yield.NEWS12: WRAPUP 2-WHO warns against vaccine hoarding as poorer countries go without.NEWS13: Johnson & Johnson Appoints Senior Leaders to Executive Committee.NEWS14: UPDATE 3-People with health issues or inactivated vaccine should get COVID-19 booster - WHO.NEWS15: 3 Investors Pick Their Favorite Dividend Stocks.
2021-12-10: NEWS1: 3 Healthcare Stocks for Long-Term Dividend Growth.NEWS2: Doctor: 'We're just going to keep recycling COVID' without proper measures.NEWS3: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results.NEWS4: Here's What Investors Need to Know About Johnson & Johnson's Split.NEWS5: Is Johnson & Johnson's Upcoming Split Good or Bad News for Investors?.NEWS6: 4 Stocks That Could Be Worth $1 Trillion by 2035.NEWS7: Moderna stock drops after posting interim data for mRNA flu vaccine.NEWS8: Pfizer, BioNTech Booster Gets FDA Nod for 16- & 17-Year Olds.NEWS9: J&J's (JNJ) COVID-19 Booster Jab Gets WHO Recommendation.NEWS10: Why You Should Buy Moderna Stock at Every Dip.NEWS11: UPDATE 3-South Africa says no signal of increased Omicron severity yet.
2021-12-13: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: J&J Turned Away by U.S. Supreme Court Over Talc Cancer Suits.NEWS3: Dws Croci(r) U.s. Vip Buys SS&C Technologies Holdings Inc, Meta Platforms Inc, Johnson ....NEWS4: The Fed could tweak monetary policy based on Build Back Better passage, economist says.NEWS5: Omicron: We don't know the full effect of latest variant, doctor explains.NEWS6: Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients.NEWS7: The Zacks Analyst Blog Highlights: Pfizer, BNTX, Moderna, and J&J.NEWS8: Coronavirus: 'We need to vaccinate the unvaccinated,' doctor urges.NEWS9: UPDATE 1-U.S. Supreme Court snubs J&J's bid to avoid Mississippi talc lawsuit.NEWS10: U.S. Supreme Court snubs J&J's bid to avoid Mississippi talc lawsuit.NEWS11: U.S. Supreme Court snubs J&J's bid to avoid Mississippi talc lawsuit.NEWS12: Janssen Secures Conditional EU Marketing Authorization For Rybrevant in Lung Cancer Setting.NEWS13: U.S. Supreme Court snubs J&J's bid to avoid Mississippi talc lawsuit.NEWS14: COVID-19: U.S. coronavirus deaths near 800,000.
2021-12-14: NEWS1: U.S. study suggests COVID-19 vaccines may be ineffective against Omicron without booster.NEWS2: Pfizer early study shows vaccine is 70% effective against Omicron variant as cases rise globally.NEWS3: Merck's (MRK) HIV Studies on Islatravir Put on Clinical Hold.NEWS4: Pfizer finds COVID pill 89% effective, some hospitals drop vaccine mandates amid labor shortage.NEWS5: Pfizer Stops 70% Omicron Hospitalizations in South Africa Study.NEWS6: No Omicron deaths in J&J vaccine study in South Africa, scientist says.NEWS7: UPDATE 5-Pfizer shot less effective in South Africa after Omicron emerges - study.NEWS8: DWS CROCI(R) U.S. Fund Buys SS&C Technologies Holdings Inc, Meta Platforms Inc, Johnson ....
2021-12-15: NEWS1: Top 10 Stocks to Buy According to Legendary Value Investor Joel Greenblatt.NEWS2: Teva Pharmaceutical Finance Netherlands IV BV -- Moody's affirms Teva's Ba2 ratings; outlook revised to stable.NEWS3: Omicron variant accounts for 3% of U.S. COVID-19 cases, doctor notes that 'it's still early'.NEWS4: Unvaccinated Google employees could face termination next year.NEWS5: COVID-19: ‘We have the tools to fight Omicron,’ doctor says.NEWS6: European Medicines Committee Backs Johnson & Johnson's COVID-19 Booster Dose.NEWS7: Lilly (LLY) Phase III Study in Ulcerative Colitis Meets Goal.NEWS8: Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine.NEWS9: Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine.NEWS10: UPDATE 1-EU regulator backs J&J COVID-19 booster dose for adults.NEWS11: European Medicines Agency to recommend Johnson & Johnson COVID booster.NEWS12: Large Company Value Portfolio Buys Fresenius Medical Care AG. ....NEWS13: UPDATE 2-Sanofi, GSK say COVID-19 vaccine booster candidate give good immune response.

Answer: Rise